![Joseph A. Mollica](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph A. Mollica
Keine laufenden Positionen mehr
Karriereverlauf von Joseph A. Mollica
Ehemalige bekannte Positionen von Joseph A. Mollica
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEUROCRINE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 24.02.2012 | 17.10.2017 |
Vorsitzender | 01.06.1997 | 24.02.2012 | |
Independent Dir/Board Member | 01.06.1997 | 17.10.2017 | |
CELATOR PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 01.08.2014 | 12.07.2016 |
Vorsitzender | 01.01.2007 | 01.08.2014 | |
Independent Dir/Board Member | 01.01.2007 | 12.07.2016 | |
REDPOINT BIO CORPORATION | Vorsitzender | 19.12.2007 | 08.01.2010 |
Linguagen Corp.
![]() Linguagen Corp. Pharmaceuticals: OtherHealth Technology Linguagen Corp. researches and develops oral medicines. The firm also develops taste blockers and enhancers. The company was founded by Robert Margolskee in 1995 and is headquartered in Cranbury, NJ. | Direktor/Vorstandsmitglied | - | 01.01.2010 |
Pharmacopeia LLC
![]() Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Vorsitzender | 01.01.2004 | 01.12.2008 |
Präsident | 01.01.2004 | 01.12.2008 | |
IMPATH, Inc. | Direktor/Vorstandsmitglied | - | 28.11.2005 |
ACCELRYS, INC. | Vorsitzender | 01.01.1994 | 01.01.2004 |
Präsident | 01.01.1994 | 01.01.2004 | |
E I DU PONT DE NEMOURS AND CO | Corporate Officer/Principal | 01.01.1987 | 01.12.1993 |
DuPont Merck Pharmaceutical Co.
![]() DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Präsident | 01.01.1987 | 01.01.1993 |
░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Joseph A. Mollica
University of Rhode Island | Doctorate Degree |
University of Wisconsin | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 15 |
Operativ
Director/Board Member | 6 |
Chairman | 5 |
President | 3 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 11 |
---|---|
BIOVIA, Inc.
![]() BIOVIA, Inc. Packaged SoftwareTechnology Services BIOVIA, Inc. develops and commercializes scientific informatics software products and services for industries and organizations that rely on scientific innovation. Its enterprise platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. The company by incorporating its capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, it enables scientific innovators to access, organize, analyze and share data in various ways. BIOVIA was founded in 1993 and is headquartered in San Diego, CA. | Technology Services |
Genencor International, Inc.
![]() Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
Pharmacopeia LLC
![]() Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
IMPATH, Inc. | Health Services |
DuPont Merck Pharmaceutical Co.
![]() DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Linguagen Corp.
![]() Linguagen Corp. Pharmaceuticals: OtherHealth Technology Linguagen Corp. researches and develops oral medicines. The firm also develops taste blockers and enhancers. The company was founded by Robert Margolskee in 1995 and is headquartered in Cranbury, NJ. | Health Technology |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
![]() Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Redpoint Bio Corp.
![]() Redpoint Bio Corp. Food: Specialty/CandyConsumer Non-Durables Redpoint Bio Corp. is a development stage biotechnology company, which engages in the discovery and development of novel taste modulators for the food, beverage, and pharmaceutical industries. The company was founded by Robert F. Margolskee and Shawn M. Marcell in August 1995 and headquartered in Philadelphia, PA. | Consumer Non-Durables |
Ciba-Geigy Corp. | Health Technology |
EIDP, Inc.
![]() EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Celator Pharmaceuticals, Inc.
![]() Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Celator Pharmaceuticals, Inc. engages in the research and development of biopharmaceutical products. The company was founded by Lawrence David Mayer, and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ. | Health Technology |
- Börse
- Insiders
- Joseph A. Mollica
- Erfahrung